Search - tctmd.com

Displaying 301 - 320 of 464

Sort: Relevancy | Date

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Daily News

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

L.A. McKeown

February 15, 2018

News Daily News

AHA Releases Scientific Statement on Breast Cancer and CVD

L.A. McKeown

February 01, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

News Daily News

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

L.A. McKeown

December 01, 2017

News Conference News AHA 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Yael L. Maxwell

November 27, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Daily News

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

L.A. McKeown

September 25, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

More Liberal Definition of Type 2 MI May Misclassify Some Patients

Todd Neale

September 20, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Conference News ESC 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

Todd Neale

September 08, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Michael O'Riordan

August 26, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

Advertisement

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

AHA Releases Scientific Statement on Breast Cancer and CVD

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

More Liberal Definition of Type 2 MI May Misclassify Some Patients

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Acute MI Mortality Has Dropped to Very Low Levels in France

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Evolocumab Not Cost-Effective at Current List Price

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content